These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Tool to assess causality of direct and indirect adverse events associated with therapeutic interventions. Zorzela L; Mior S; Boon H; Gross A; Yager J; Carter R; Vohra S Curr Med Res Opin; 2018 Mar; 34(3):407-414. PubMed ID: 28933962 [TBL] [Abstract][Full Text] [Related]
63. Validity of anecdotal reports of suspected adverse drug reactions: the problem of false alarms. Venning GR Br Med J (Clin Res Ed); 1982 Jan; 284(6311):249-52. PubMed ID: 6799125 [TBL] [Abstract][Full Text] [Related]
64. Measuring interrater reliability among multiple raters: an example of methods for nominal data. Posner KL; Sampson PD; Caplan RA; Ward RJ; Cheney FW Stat Med; 1990 Sep; 9(9):1103-15. PubMed ID: 2244082 [TBL] [Abstract][Full Text] [Related]
65. Specific agreement on ordinal and multiple nominal outcomes can be calculated for more than two raters. de Vet HCW; Mullender MG; Eekhout I J Clin Epidemiol; 2018 Apr; 96():47-53. PubMed ID: 29217452 [TBL] [Abstract][Full Text] [Related]
66. Ertapenem-Induced Encephalopathy in a Patient With Normal Renal Function. Sutton SS; Jumper M; Cook S; Edun B; Wyatt MD J Investig Med High Impact Case Rep; 2017; 5(1):2324709616689376. PubMed ID: 28203577 [TBL] [Abstract][Full Text] [Related]
67. Assessing methods for causality assessment of suspected adverse drug reactions. Hutchinson TA; Lane DA J Clin Epidemiol; 1989; 42(1):5-16. PubMed ID: 2913186 [TBL] [Abstract][Full Text] [Related]
68. A scale for assessing the severity of diseases and adverse drug reactions. Application to drug benefit and risk. Tallarida RJ; Murray RB; Eiben C Clin Pharmacol Ther; 1979 Apr; 25(4):381-90. PubMed ID: 428184 [TBL] [Abstract][Full Text] [Related]
69. The value of case reports. Dearlove O; Vashist R Anaesthesia; 2001 Jul; 56(7):690-1. PubMed ID: 11437778 [No Abstract] [Full Text] [Related]
70. Reports of adverse drug reactions in general medical journals. O'Connor PC; McCabe J; Lawson DH Ir J Med Sci; 1982 Jun; 151(6):184-7. PubMed ID: 7107178 [No Abstract] [Full Text] [Related]
71. Role of medical journals in adverse drug reaction alerts. Haramburu F; Begaud B; Pere JC; Marcel S; Albin H Lancet; 1985 Sep; 2(8454):550-1. PubMed ID: 2863560 [No Abstract] [Full Text] [Related]
72. Comparison of agreement and rational uses of the WHO and Naranjo adverse event causality assessment tools. Mittal N; Gupta MC J Pharmacol Pharmacother; 2015; 6(2):91-3. PubMed ID: 25969656 [No Abstract] [Full Text] [Related]
73. Case reports and causality. Gilbert FI Ann Intern Med; 1994 Apr; 120(8):696. PubMed ID: 8135465 [No Abstract] [Full Text] [Related]
74. A bright future for JMT. Dye L J Med Toxicol; 2011 Dec; 7(4):255. PubMed ID: 22038189 [No Abstract] [Full Text] [Related]
75. Methods for individualized assessment of absolute risk in case-control studies should be weighted carefully. Haaf KT; Steyerberg EW Eur J Epidemiol; 2016 Nov; 31(11):1067-1068. PubMed ID: 27738831 [No Abstract] [Full Text] [Related]
76. Erratum: Evaluation of the Modified Naranjo Criteria for Assessing Causal Attribution of Clinical Outcome to Homeopathic Intervention as Presented in Case Reports. Lamba CD; Gupta VK; van Haselen R; Rutten L; Mahajan N; Molla AM; Singhal R Homeopathy; 2020 Nov; 109(4):e1-e2. PubMed ID: 33086424 [No Abstract] [Full Text] [Related]
77. Synthesis of case reports for meta-assessment of causality. Phelan PS BMJ Evid Based Med; 2018 Oct; 23(5):200. PubMed ID: 29848544 [No Abstract] [Full Text] [Related]
78. Editorial: APS now leaves copyright with authors for derivative works. Sprouse GD Phys Rev E Stat Nonlin Soft Matter Phys; 2008 Oct; 78(4 Pt 1):040001. PubMed ID: 18999363 [No Abstract] [Full Text] [Related]
79. Evaluation of aniseikonic case reports. MILES PW Am J Ophthalmol; 1949 Jun; Pt.1 32(6):835-8. PubMed ID: 18150612 [No Abstract] [Full Text] [Related]